Cargando…
Altered levels of lymphocyte enhancer-binding factor-1 modulates the pigmentation in acral and non-acral lesions of non-segmental vitiligo patients: a follow-up-based study in North India
BACKGROUND: Lymphocyte enhancer-binding factor-1 (LEF1) is responsible for melanocyte proliferation, migration and differentiation and its downregulation may result in depigmentation in vitiligo. Narrowband UVB (NB-UVB) phototherapy is known to enhance melanocyte migration from hair follicles to les...
Autores principales: | Nayak, Debidutt, Srivastava, Niharika, Dev, Anubha, Bishnoi, Anuradha, Kumaran, Muthu Sendhil, Vinay, Keshavamurthy, Parsad, Davinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987393/ https://www.ncbi.nlm.nih.gov/pubmed/36877308 http://dx.doi.org/10.1007/s00403-023-02585-7 |
Ejemplares similares
-
Extrafacial Melasma: A Scenario Less Explored
por: Daroach, Manju, et al.
Publicado: (2022) -
Covid-19 Vaccination and Chronic Urticaria: A Paradigm Study
por: Dev, Anubha, et al.
Publicado: (2023) -
COVID-19 Pandemic and Vitiligo: Changing Paradigms
por: Narayan, R Vignesh, et al.
Publicado: (2022) -
Acquired Dermal Macular Hyperpigmentation: An Update
por: Vinay, Keshavamurthy, et al.
Publicado: (2021) -
Comparing azathioprine with cyclosporine in the treatment of antihistamine refractory chronic spontaneous urticaria: A randomized prospective active-controlled non-inferiority study()
por: Pathania, Yashdeep Singh, et al.
Publicado: (2019)